Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
2.
BMC Infect Dis ; 14: 163, 2014 Mar 25.
Article in English | MEDLINE | ID: mdl-24661335

ABSTRACT

BACKGROUND: Innate defence mechanisms of the airways are impaired in chronic obstructive pulmonary disease (COPD), predisposing patients to lower respiratory tract infections, but less is known about the association with other infections. In this population-based cohort study, we investigated the associations between COPD and invasive bacterial disease by comparing incidence rates of bacteraemia in COPD patients and randomly selected reference individuals from the general population. METHODS: In this population based cohort study all patients with COPD, ≥40 years of age, who were discharged from hospitals in southern Sweden between 1990 and 2003 were identified in the Swedish Inpatient Register (n = 15,403). Age and gender matched reference individuals were randomly selected from the general population. Records were cross-referenced to the microbiological databases covering the region, 1990-2010. The hazard ratios (HR) of bloodstream infections and hospitalisations for infections were estimated by Cox proportional hazards regression. RESULTS: We found that individuals with COPD had a 2.5-fold increased incidence of bacteraemia compared to the reference individuals from the general population adjusted for other co-morbidity and socio-economic status (hazard ratio: 2.5, 95% confidence interval: 2.2-2.7). The increased incidence of bacteraemia was paralleled by an increased incidence of hospitalisation for non-respiratory infections, i.e., skin infections, pyelonephritis, or septic arthritis. Despite higher absolute rates of bloodstream infections among COPD patients than among the general population, the distribution of different pathogens was similar. CONCLUSIONS: In summary this population-based study shows COPD is associated with an increased incidence of invasive bacterial infections compared to the general population, indicating a general frailty of acquiring severe infections in addition to the specific susceptibility to infections of respiratory origin. The underlying contributory factors (e.g. smoking, corticosteroid use, co-morbid diseases or a frailty inherent to COPD itself) need to be disentangled in further studies.


Subject(s)
Bacteremia/microbiology , Bacteremia/pathology , Pulmonary Disease, Chronic Obstructive/microbiology , Pulmonary Disease, Chronic Obstructive/pathology , Adult , Aged , Aged, 80 and over , Bacteremia/epidemiology , Cohort Studies , Female , Humans , Incidence , Male , Middle Aged , Pulmonary Disease, Chronic Obstructive/epidemiology , Sweden/epidemiology
3.
AIDS ; 26(14): 1739-44, 2012 Sep 10.
Article in English | MEDLINE | ID: mdl-22695299

ABSTRACT

OBJECTIVE: To study the use of major and alternative coreceptors by HIV-1 isolates obtained from paired plasma and cerebrospinal fluid (CSF) samples. DESIGN: Paired plasma and CSF isolates from HIV-1-infected individuals with varying clinical, virologic, and immunologic parameters were assessed for the ability to infect indicator cells expressing a panel of coreceptors with documented expression in the central nervous system (CNS). METHODS: HIV-1 isolates obtained from plasma and CSF in 28 individuals with varying viral load, CD4 T-cell counts, and with or without AIDS-defining disease were analyzed for the ability to infect NP2.CD4 cells stably expressing a panel of HIV coreceptors (CCR5, CXCR4, CCR3, CXCR6, GPR1, APJ, ChemR23, RDC-1 or BLT1). RESULTS: All isolates from both plasma and CSF utilized CCR5 and/or CXCR4. However, the ability to use both CCR3 and CCR5 (R3R5) was more pronounced in CSF isolates and correlated with high CSF viral load and low CD4 T-cell count. Notably, four out of five CSF isolates of subtype C origin exhibited CXCR6 use, which coincided with high CSF viral load despite preserved CD4 T-cell counts. The use of other alternative coreceptors was less pronounced. CONCLUSION: Dual-tropic R3R5 HIV-1 isolates in CSF coincide with high CSF viral load and low CD4 T-cell counts. Frequent CXCR6 use by CSF-derived subtype C isolates indicates that subtype-specific differences in coreceptor use may exist that will not be acknowledged when assessing plasma virus isolates. The findings may also bare relevance for HIV-1 replication within the CNS, and consequently, for the neuropathogenesis of AIDS.


Subject(s)
AIDS Dementia Complex/metabolism , Acquired Immunodeficiency Syndrome/metabolism , CD4-Positive T-Lymphocytes/metabolism , HIV Seropositivity/metabolism , HIV-1/metabolism , Receptors, Chemokine/metabolism , Tropism , Viral Load , AIDS Dementia Complex/cerebrospinal fluid , AIDS Dementia Complex/genetics , AIDS Dementia Complex/physiopathology , Acquired Immunodeficiency Syndrome/cerebrospinal fluid , Acquired Immunodeficiency Syndrome/genetics , Acquired Immunodeficiency Syndrome/physiopathology , CD4 Lymphocyte Count , Female , Genotype , HIV Seropositivity/cerebrospinal fluid , HIV Seropositivity/genetics , HIV Seropositivity/physiopathology , HIV-1/isolation & purification , Humans , Male , Phenotype , Receptors, CCR5/metabolism , Receptors, CXCR4/metabolism , Receptors, CXCR6 , Receptors, Chemokine/genetics , Receptors, HIV/metabolism , Receptors, Virus/metabolism , Retrospective Studies , Tropism/genetics
4.
PLoS One ; 5(4): e10138, 2010 Apr 13.
Article in English | MEDLINE | ID: mdl-20405056

ABSTRACT

BACKGROUND: Both chronic obstructive pulmonary disease (COPD) and tuberculosis (TB) primarily affect the lungs and are major causes of morbidity and mortality worldwide. COPD and TB have common risk factors such as smoking, low socioeconomic status and dysregulation of host defence functions. COPD is a prevalent co-morbid condition, especially in elderly with TB but in contrast to other diseases known to increase the risk of TB, relatively little is known about the specific relationship and impact from COPD on TB-incidence and mortality. METHODS AND FINDINGS: All individuals > or = 40 years of age, discharged with a diagnosis of COPD from Swedish hospitals 1987-2003 were identified in the Swedish Inpatient Register (n = 115,867). Records were linked to the Swedish Tuberculosis Register 1989-2007 and the relative risk of active TB in patients with COPD compared to control subjects randomly selected from the general population (matched for sex, year of birth and county of residence) was estimated using Cox regression. The analyses were stratified by year of birth, sex and county of residence and adjusted for immigration status, socioeconomic status (SES) and inpatient co-morbidities previously known to increase the risk of TB. COPD patients had a three-fold increased hazard ratio (HR) of developing active TB (HR 3.0 (95% confidence interval 2.4 to 4.0)) that was mainly dependent on an increased risk of pulmonary TB. In addition, logistic regression estimates showed that COPD patients who developed active TB had a two-fold increased risk of death from all causes within first year after the TB diagnosis compared to the general population control subjects with TB (OR 2.2, 95% confidence interval 1.2 to 4.1). CONCLUSIONS: This population-based study comprised of a large number of COPD patients shows that these patients have an increased risk of developing active TB compared to the general population. The results raise concerns that the increasing global burden of COPD will increase the incidence of active TB. The underlying contributory factors need to be disentangled in further studies.


Subject(s)
Pulmonary Disease, Chronic Obstructive/complications , Tuberculosis/etiology , Adult , Aged , Aged, 80 and over , Cohort Studies , Data Collection , Female , Humans , Incidence , Male , Middle Aged , Proportional Hazards Models , Pulmonary Disease, Chronic Obstructive/epidemiology , Regression Analysis , Risk , Sweden/epidemiology , Tuberculosis/epidemiology , Tuberculosis/mortality
5.
AIDS Res Hum Retroviruses ; 25(12): 1297-1305, 2009 Dec.
Article in English | MEDLINE | ID: mdl-20001314

ABSTRACT

Through the use of chimeric CXCR4/CCR5 receptors we have previously shown that CCR5-tropic (R5) HIV-1 isolates acquire a more flexible receptor use over time, and that this links to a reduced viral susceptibility to inhibition by the CCR5 ligand RANTES. These findings may have relevance with regards to the efficacy of antiretroviral compounds that target CCR5/virus interactions. Compartmentalized discrepancies in coreceptor use may occur, which could also affect the efficacy of these compounds at specific anatomical sites, such as within the CNS. In this cross-sectional study we have used wild-type CCR5 and CXCR4 as well as chimeric CXCR4/CCR5 receptors to characterize coreceptor use by paired plasma and cerebrospinal fluid (CSF) isolates from 28 HIV-1-infected individuals. Furthermore, selected R5 isolates, with varying chimeric receptor use, were tested for sensitivity to inhibition by the CCR5 antagonist TAK-779. Discordant CSF/plasma virus coreceptor use was found in 10/28 patients. Low CD4+ T cell counts correlated strongly with a more flexible mode of R5 virus CCR5 usage, as disclosed by an increased ability to utilize chimeric CXCR4/CCR5 receptors, specifically receptor FC-2. Importantly, an elevated ability to utilize chimeric receptors correlated with a reduced susceptibility to inhibition by TAK-779. Our findings show that a discordant CSF and plasma virus coreceptor use is not uncommon. Furthermore, we provide support for an emerging paradigm, where the acquisition of a more flexible mode of CCR5 usage is a key event in R5 virus pathogenesis. This may, in turn, negatively impact the efficacy of CCR5 antagonist treatment in late stage HIV-1 disease.


Subject(s)
HIV Infections/virology , HIV-1/drug effects , Leukocytes, Mononuclear/metabolism , Amides/pharmacology , CCR5 Receptor Antagonists , CD4 Lymphocyte Count , Cell Line, Tumor , Cells, Cultured , Chemokine CCL5/metabolism , Cross-Sectional Studies , HIV Infections/blood , HIV Infections/cerebrospinal fluid , HIV-1/metabolism , Humans , Leukocytes, Mononuclear/drug effects , Leukocytes, Mononuclear/virology , Quaternary Ammonium Compounds/pharmacology , Receptors, CCR5/metabolism , Receptors, CXCR4/drug effects , Receptors, CXCR4/metabolism , Recombinant Fusion Proteins/drug effects , Recombinant Fusion Proteins/metabolism , Transfection , Viral Load/drug effects
6.
Pharm World Sci ; 30(1): 92-8, 2008 Jan.
Article in English | MEDLINE | ID: mdl-17661157

ABSTRACT

OBJECTIVE: To investigate whether a Medication Report can reduce the number of medication errors when elderly patients are discharged from hospital. METHOD: We conducted a prospective intervention with retrospective controls on patients at three departments at Lund University Hospital, Sweden that where transferred to primary care. The intervention group, where patients received a Medication Report at discharge, was compared with a control group with patients of the same age, who were not given a Medication Report when discharged from the same ward one year earlier. MAIN OUTCOME MEASURES: The main outcome measure was the number of medication errors when elderly patients were discharged from hospital. RESULTS: Among 248 patients in the intervention group 79 (32%) had at least one medication error as compared with 118 (66%) among the 179 patients in the control group. In the intervention group 15% of the patients had errors that were considered to have moderate or high risk of clinical consequences compared with 32% in the control group. The differences were statistically significant (P<0.001). CONCLUSION: Medication errors are common when elderly patients are discharged from hospital. The Medication Report is a simple tool that reduces the number of medication errors.


Subject(s)
Drug Utilization Review , Medication Errors/prevention & control , Outcome and Process Assessment, Health Care , Patient Discharge , Pharmacy Service, Hospital/organization & administration , Aged , Aged, 80 and over , Drug Prescriptions , Female , Hospitals, University , Humans , Male , Pharmacists , Prospective Studies , Sweden
7.
J Leukoc Biol ; 77(6): 1018-25, 2005 Jun.
Article in English | MEDLINE | ID: mdl-15728714

ABSTRACT

The high-affinity leukotriene B(4) (LTB(4)) receptor, BLT1, is a chemotactic receptor involved in inflammatory responses. In this study, we have explored the regulation of BLT1 expression in human monocytes by pro- and anti-inflammatory cytokines, lipopolysaccharide (LPS), and dexamethasone. We found that proinflammatory mediators, such as interferon-gamma (IFN-gamma), tumor necrosis factor-alpha, and LPS, down-regulated expression, whereas the anti-inflammatory cytokine, interleukin-10, and dexamethasone up-regulated BLT1 mRNA expression. The effect of IFN-gamma on BLT1 mRNA expression was rapidly detectable (<4 h) and concentration-dependent (1-50 ng/ml) and seems to be exerted through a block in transcriptional activity. Alterations in mRNA expression were accompanied by changes in BLT1 surface expression, and receptor down-modulation following IFN-gamma stimulation resulted in a diminished chemotactic response to LTB(4). The regulation of BLT1 mRNA and receptor protein expression was similar to the regulation of the monocyte chemoattractant protein-1 chemokine receptor, CC chemokine recptor 2 (CCR2). Flow cytometric analysis of fresh peripheral blood cells revealed that classical (CD14(++)CD16(-)) monocytes express high levels of BLT1 and CCR2 and that both receptors are down-regulated on CD14(+)CD16(+) monocytes. Apart from providing insight into the regulation of BLT1 in human monocytes, our results reveal a parallel expression and regulation of BLT1 and CCR2, which may help to understand monocyte trafficking during pathophysiological conditions.


Subject(s)
Inflammation Mediators/pharmacology , Monocytes/immunology , Receptors, Leukotriene/metabolism , Chemotaxis/drug effects , Dexamethasone/pharmacology , Down-Regulation , Humans , Interferon-gamma/pharmacology , Interleukin-10/pharmacology , Lipopolysaccharides/pharmacology , Monocytes/drug effects , RNA Stability , RNA, Messenger/analysis , RNA, Messenger/metabolism , Receptors, Leukotriene/genetics , Receptors, Leukotriene B4 , Receptors, Purinergic P2 , Tumor Necrosis Factor-alpha/pharmacology , Up-Regulation
9.
Scand J Infect Dis ; 34(1): 17-21, 2002.
Article in English | MEDLINE | ID: mdl-11874159

ABSTRACT

The impact of antineoplastic drugs on the intestinal microflora was studied in 9 patients with acute leukaemia during chemotherapy and in 5 patients also during chemotherapy-induced neutropenia. Quantitative and qualitative microbiological analyses of faecal samples obtained before and during chemotherapy showed significantly increased counts of Bacteroides spp. in 3/9 patients and, during neutropenia, significantly increased counts of yeasts in 2/5 patients; however, the intestinal microflora was stable in most patients.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/pharmacology , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Intestines/microbiology , Leukemia, Myeloid, Acute/drug therapy , Precursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapy , Adult , Aged , Antineoplastic Combined Chemotherapy Protocols/adverse effects , Bacteroides/drug effects , Colony Count, Microbial , Escherichia coli/drug effects , Female , Gram-Positive Bacteria/drug effects , Gram-Positive Bacteria/isolation & purification , Humans , Intestines/drug effects , Male , Middle Aged , Neutropenia/chemically induced , Yeasts/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...